After the publication of this article [1], concerns were raised that Actin panel lanes 3, 4 in Fig 7A appear similar to lanes 5, 6.
The authors explained that this duplication was due to an error during figure preparation and provided an updated figure along with the original, underlying images to the journal. The underlying images provided did not fully match the updated figure thus not resolving the concerns satisfactorily. A member of our Editorial Board concluded that the updated figure did not support p-ERK 1/2 activation as described in the results.
In light of the unresolved concerns that question the validity of the findings, the PLOS ONE Editors retract this article.
SS, MS, RT, MG agreed with retraction. IWYM did not respond.
Reference
- 1. Singh S, Singh M, Mak IWY, Turcotte R, Ghert M (2012) Investigation of FGFR2-IIIC Signaling via FGF-2 Ligand for Advancing GCT Stromal Cell Differentiation. PLoS ONE 7(10): e46769. https://doi.org/10.1371/journal.pone.0046769 pmid:23071632
Citation: The PLOS ONE Editors (2019) Retraction: Investigation of FGFR2-IIIC Signaling via FGF-2 Ligand for Advancing GCT Stromal Cell Differentiation. PLoS ONE 14(7): e0220356. https://doi.org/10.1371/journal.pone.0220356
Published: July 23, 2019
Copyright: © 2019 The PLOS ONE Editors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.